Analysts Issue Forecasts for CLDX Q1 Earnings
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Investment analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Celldex Therapeutics in a research note issued on Thursday, February 13th. Leerink Partnrs analyst T. Smith anticipates that the biopharmaceutical company will earn ($0.65) per share for the quarter. The consensus estimate for […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Investment analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Celldex Therapeutics in a research note issued on Thursday, February 13th. Leerink Partnrs analyst T. Smith anticipates that the biopharmaceutical company will earn ($0.65) per share for the quarter. The consensus estimate for […]
